New Key Statistics Module, Z-Score and F-Score
NAS:TLX Key Ratios
| Market Cap $ M | 5,171.42 |
| Enterprise Value $ M | 5,211.04 |
| P/E(ttm) | 1,404.55 |
| PE Ratio without NRI | 1,287.50 |
| Forward PE Ratio | 96.56 |
| Price/Book | 20.33 |
| Price/Sales | 12.42 |
| Price/Free Cash Flow | 379.79 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 424.00 |
| EPS (TTM) $ | 0.01 |
| Beneish M-Score | -0.61 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 119.09 |
| EV-to-EBITDA | 107.24 |
| PEG | -- |
| Shares Outstanding M | 334.72 |
| Net Margin (%) | 7.72 |
| Operating Margin % | 12.49 |
| Pre-tax Margin (%) | 7.86 |
| Quick Ratio | 0.87 |
| Current Ratio | 0.99 |
| ROA % (ttm) | 10.14 |
| ROE % (ttm) | 23.46 |
| ROIC % (ttm) | 21.54 |
| Dividend Yield % | -- |
| Altman Z-Score | 20.56 |
TLX Number of Guru Trades
TLX Volume of Guru Trades
Gurus Latest Trades with NAS:TLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TLX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Telix Pharmaceuticals Ltd Insider Transactions
No Available Data
News about NAS:TLX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers